|
nasdaq:lmnx
|
487553
|
Apr 14th, 2024 12:00AM
|
Nanosphere
|
2.2K
|
41.00
|
Open
|
|
Apr 13th, 2024 11:18PM
|
Apr 13th, 2024 11:18PM
|
Nanosphere is dedicated to enhancing medicine by providing targeted molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment and improved healthcare economics.
Nanosphere’s platform, the Verigene® System, enables clinicians to rapidly identify and treat the bacteria and viruses responsible for some of the most complex, costly and deadly infectious diseases.
Headquartered in Northbrook, Illinois, Nanosphere was founded in 1999 based upon technology developed at Northwestern University by Dr. Robert Letsinger and Dr. Chad Mirkin. In 2007, Nanosphere went public (NASDAQ: NSPH), and has remained committed to continued scientific discovery and innovation with more than 175 patents to its name.
Currently, our test menu targets infections of the bloodstream, respiratory tract and gastrointestinal tract.
Nanosphere is now a Luminex company.
|
Open
|
|
Open
|
4088 Commercial Ave.
|
Northbrook
|
IL
|
US
|
60062
|
|
Luminex
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:lmnx
|
14089
|
Apr 14th, 2024 12:00AM
|
Luminex
|
24K
|
1041
|
Open
|
|
Apr 13th, 2024 11:18PM
|
Apr 13th, 2024 11:18PM
|
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at diasorin.com.
Twitter: @Luminex
Facebook: facebook.com/LuminexCorp/
Instagram: @luminexcorporation
YouTube: https://www.youtube.com/@Luminexcorporation
|
Open
|
Molecular Diagnostics, xMAP Technology, Life Science Research, Multiplexing, and Biotechnology
|
Open
|
12212 Technology Blvd
|
Austin
|
TX
|
US
|
78727
|
|
Luminex
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:lmnx
|
14089
|
Apr 13th, 2024 12:00AM
|
Luminex
|
24K
|
1041
|
Open
|
|
Apr 12th, 2024 11:09PM
|
Apr 13th, 2024 11:43AM
|
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at diasorin.com.
Twitter: @Luminex
Facebook: facebook.com/LuminexCorp/
Instagram: @luminexcorporation
YouTube: https://www.youtube.com/@Luminexcorporation
|
Open
|
Molecular Diagnostics, xMAP Technology, Life Science Research, Multiplexing, and Biotechnology
|
Open
|
12212 Technology Blvd
|
Austin
|
TX
|
US
|
78727
|
|
Luminex
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:lmnx
|
487553
|
Apr 13th, 2024 12:00AM
|
Nanosphere
|
2.2K
|
41.00
|
Open
|
|
Apr 12th, 2024 11:09PM
|
Apr 13th, 2024 11:43AM
|
Nanosphere is dedicated to enhancing medicine by providing targeted molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment and improved healthcare economics.
Nanosphere’s platform, the Verigene® System, enables clinicians to rapidly identify and treat the bacteria and viruses responsible for some of the most complex, costly and deadly infectious diseases.
Headquartered in Northbrook, Illinois, Nanosphere was founded in 1999 based upon technology developed at Northwestern University by Dr. Robert Letsinger and Dr. Chad Mirkin. In 2007, Nanosphere went public (NASDAQ: NSPH), and has remained committed to continued scientific discovery and innovation with more than 175 patents to its name.
Currently, our test menu targets infections of the bloodstream, respiratory tract and gastrointestinal tract.
Nanosphere is now a Luminex company.
|
Open
|
|
Open
|
4088 Commercial Ave.
|
Northbrook
|
IL
|
US
|
60062
|
|
Luminex
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:lmnx
|
14089
|
Apr 12th, 2024 12:00AM
|
Luminex
|
24K
|
1039
|
Open
|
|
Apr 11th, 2024 11:14PM
|
Apr 12th, 2024 08:38AM
|
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at diasorin.com.
Twitter: @Luminex
Facebook: facebook.com/LuminexCorp/
Instagram: @luminexcorporation
YouTube: https://www.youtube.com/@Luminexcorporation
|
Open
|
Molecular Diagnostics, xMAP Technology, Life Science Research, Multiplexing, and Biotechnology
|
Open
|
12212 Technology Blvd
|
Austin
|
TX
|
US
|
78727
|
|
Luminex
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:lmnx
|
487553
|
Apr 12th, 2024 12:00AM
|
Nanosphere
|
2.2K
|
41.00
|
Open
|
|
Apr 11th, 2024 11:14PM
|
Apr 12th, 2024 08:38AM
|
Nanosphere is dedicated to enhancing medicine by providing targeted molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment and improved healthcare economics.
Nanosphere’s platform, the Verigene® System, enables clinicians to rapidly identify and treat the bacteria and viruses responsible for some of the most complex, costly and deadly infectious diseases.
Headquartered in Northbrook, Illinois, Nanosphere was founded in 1999 based upon technology developed at Northwestern University by Dr. Robert Letsinger and Dr. Chad Mirkin. In 2007, Nanosphere went public (NASDAQ: NSPH), and has remained committed to continued scientific discovery and innovation with more than 175 patents to its name.
Currently, our test menu targets infections of the bloodstream, respiratory tract and gastrointestinal tract.
Nanosphere is now a Luminex company.
|
Open
|
|
Open
|
4088 Commercial Ave.
|
Northbrook
|
IL
|
US
|
60062
|
|
Luminex
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:lmnx
|
487553
|
Apr 11th, 2024 12:00AM
|
Nanosphere
|
2.2K
|
41.00
|
Open
|
|
Apr 10th, 2024 11:47PM
|
Apr 11th, 2024 11:24AM
|
Nanosphere is dedicated to enhancing medicine by providing targeted molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment and improved healthcare economics.
Nanosphere’s platform, the Verigene® System, enables clinicians to rapidly identify and treat the bacteria and viruses responsible for some of the most complex, costly and deadly infectious diseases.
Headquartered in Northbrook, Illinois, Nanosphere was founded in 1999 based upon technology developed at Northwestern University by Dr. Robert Letsinger and Dr. Chad Mirkin. In 2007, Nanosphere went public (NASDAQ: NSPH), and has remained committed to continued scientific discovery and innovation with more than 175 patents to its name.
Currently, our test menu targets infections of the bloodstream, respiratory tract and gastrointestinal tract.
Nanosphere is now a Luminex company.
|
Open
|
|
Open
|
4088 Commercial Ave.
|
Northbrook
|
IL
|
US
|
60062
|
|
Luminex
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:lmnx
|
14089
|
Apr 11th, 2024 12:00AM
|
Luminex
|
24K
|
1041
|
Open
|
|
Apr 10th, 2024 11:47PM
|
Apr 11th, 2024 11:24AM
|
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at diasorin.com.
Twitter: @Luminex
Facebook: facebook.com/LuminexCorp/
Instagram: @luminexcorporation
YouTube: https://www.youtube.com/@Luminexcorporation
|
Open
|
Molecular Diagnostics, xMAP Technology, Life Science Research, Multiplexing, and Biotechnology
|
Open
|
12212 Technology Blvd
|
Austin
|
TX
|
US
|
78727
|
|
Luminex
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:lmnx
|
487553
|
Apr 10th, 2024 12:00AM
|
Nanosphere
|
2.2K
|
41.00
|
Open
|
|
Apr 9th, 2024 11:17PM
|
Apr 10th, 2024 05:31PM
|
Nanosphere is dedicated to enhancing medicine by providing targeted molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment and improved healthcare economics.
Nanosphere’s platform, the Verigene® System, enables clinicians to rapidly identify and treat the bacteria and viruses responsible for some of the most complex, costly and deadly infectious diseases.
Headquartered in Northbrook, Illinois, Nanosphere was founded in 1999 based upon technology developed at Northwestern University by Dr. Robert Letsinger and Dr. Chad Mirkin. In 2007, Nanosphere went public (NASDAQ: NSPH), and has remained committed to continued scientific discovery and innovation with more than 175 patents to its name.
Currently, our test menu targets infections of the bloodstream, respiratory tract and gastrointestinal tract.
Nanosphere is now a Luminex company.
|
Open
|
|
Open
|
4088 Commercial Ave.
|
Northbrook
|
IL
|
US
|
60062
|
|
Luminex
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:lmnx
|
14089
|
Apr 10th, 2024 12:00AM
|
Luminex
|
24K
|
1041
|
Open
|
|
Apr 9th, 2024 11:17PM
|
Apr 10th, 2024 05:31PM
|
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at diasorin.com.
Twitter: @Luminex
Facebook: facebook.com/LuminexCorp/
Instagram: @luminexcorporation
YouTube: https://www.youtube.com/@Luminexcorporation
|
Open
|
Molecular Diagnostics, xMAP Technology, Life Science Research, Multiplexing, and Biotechnology
|
Open
|
12212 Technology Blvd
|
Austin
|
TX
|
US
|
78727
|
|
Luminex
|
Health Care
|
Pharmaceuticals & Biotechnology
|